Anusha Raj
Overview
Explore the profile of Anusha Raj including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
4
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gawai T, Sadawarte S, Khandagale K, Raj A, Kulkarni A, Jaiswal D, et al.
PeerJ
. 2024 Jul;
12:e17679.
PMID: 39011376
Background: Onion thrips () is a complex of cryptic species with subtle morphological differences and distinct genetic backgrounds; thus, species identification using traditional methods remains challenging. The existence of different...
2.
Mallapragda S, Gupta R, Gupta S, Sharma H, Srivastava S, Raj A
J Contemp Dent Pract
. 2024 Mar;
25(2):160-167.
PMID: 38514414
Aim: Amnion and chorion membranes possess unique inherited biological properties that enhance wound healing and may accelerate periodontal regeneration. The present study aims to evaluate and compare the efficacy of...
3.
Gowda V, Raj A, Vamyanmane D, Nagarajappa V, Srinivas S, Tirumale R, et al.
J Pediatr Genet
. 2024 Jan;
12(4):280-287.
PMID: 38162162
Hyperphosphatemic familial tumoral calcinosis (HFTC) presents with varied neurological manifestations that have been reported in the literature like facial palsy, vision and hearing impairment, stroke, and headache. In this article,...
4.
Suresh P, Jairam R, Chandrasekhar D, Vinod A, Hiremath R, Raj A, et al.
Eur J Drug Metab Pharmacokinet
. 2018 Feb;
43(4):453-460.
PMID: 29470718
Background And Objectives: Ulixertinib (BVD-523) is a novel and selective reversible inhibitor of ERK1/ERK2. The primary objectives of the study were to evaluate the pharmacokinetics of ulixertinib in mice, rats,...